BTC $79,101.21 -0.81%
ETH $2,487.34 -0.10%
BNB $739.95 -1.00%
XRP $1.40 -0.68%
SOL $104.14 -1.67%
TRX $0.3338 -0.33%
DOGE $0.0901 +1.17%
ADA $0.2211 +1.43%
BCH $261.52 +2.14%
LINK $12.92 +5.19%
HYPE $85.54 -2.38%
AAVE $132.29 -0.60%
SUI $0.8189 +3.14%
XLM $0.1915 +4.12%
ZEC $1,167.82 -3.03%
BTC $79,101.21 -0.81%
ETH $2,487.34 -0.10%
BNB $739.95 -1.00%
XRP $1.40 -0.68%
SOL $104.14 -1.67%
TRX $0.3338 -0.33%
DOGE $0.0901 +1.17%
ADA $0.2211 +1.43%
BCH $261.52 +2.14%
LINK $12.92 +5.19%
HYPE $85.54 -2.38%
AAVE $132.29 -0.60%
SUI $0.8189 +3.14%
XLM $0.1915 +4.12%
ZEC $1,167.82 -3.03%

US stock MEIP rose over 33% today, with a market value reaching 41.24 million USD

2025-07-19 00:18:45

ChainCatcher news, according to market news, MEI Pharma (NASDAQ: MEIP) rose over 33% today, with a market capitalization reaching $41.2431 million.

Previously, it was reported that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation for the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

app_icon
ChainCatcher Building the Web3 world with innovations.